Femto Technologies Secures $17 Million Investment to Advance Feminine Wellness Technology

Femto Technologies Inc., a FemTech pioneer, has secured $17 million through a private placement investment, positioning the company to advance its innovative feminine wellness technologies. The company will issue common shares and warrants to institutional investors at $4.17 per common unit, with the transaction expected to close on February 27, 2025. This substantial funding round represents a significant milestone for the company and the broader FemTech industry.

The investment structure includes the sale of common units comprising common shares, Series A warrants, and Series B PIPE common warrants. Series A warrants will have an initial exercise price of $5.21 per common share and expire 60 months after issuance, while Series B warrants will have an initial exercise price of $12.51 per common share and expire 30 months after issuance. Aegis Capital Corp. is serving as the exclusive placement agent for this private placement. The securities are being offered solely to accredited investors in a private transaction not involving a public offering, and have not been registered under the Securities Act of 1933.

Femto plans to utilize the net proceeds from the offering for general corporate purposes and working capital. The funding will specifically support further development of Sensera, the company's feminine wellness device that integrates proprietary Smart Release System technology featuring machine learning and artificial intelligence. This strategic allocation of resources underscores the company's commitment to technological innovation in women's health.

The Sensera device, which recently received a CES Innovation Awards® 2025 Honorary designation in the AI category, represents Femto's dedication to bridging gaps in feminine wellness through advanced technological solutions. The device is designed to provide a holistic self-care experience that adapts to women's changing needs, leveraging artificial intelligence to personalize user experiences. This recognition from one of the technology industry's most prestigious awards programs validates the company's innovative approach to feminine wellness.

This financial milestone underscores Femto Technologies' strategic positioning in the emerging FemTech market, signaling continued innovation and potential growth in female wellness technologies. The $17 million investment not only provides necessary capital for research and development but also demonstrates investor confidence in the company's vision and technological capabilities. As FemTech continues to gain momentum as a significant sector within healthcare technology, this funding positions Femto Technologies as a key player driving innovation and addressing previously underserved areas of women's health through cutting-edge technological solutions.